Vaccine

Blue Water Biotech Announces Preclinical Data Supporting Immunogenicity of Novel Monkeypox Vaccine Utilizing Norovirus Virus-Like Particle PlatformBlue Water Biotech Announces Preclinical Data Supporting Immunogenicity of Novel Monkeypox Vaccine Utilizing Norovirus Virus-Like Particle Platform

Blue Water Biotech Announces Preclinical Data Supporting Immunogenicity of Novel Monkeypox Vaccine Utilizing Norovirus Virus-Like Particle Platform

CINCINNATI, Ohio, June 28, 2023 (GLOBE NEWSWIRE) -- Blue Water Biotech, Inc. (“Blue Water” or the “Company”) (Nasdaq: BWV), a…

2 years ago
ExeVir Bio Awarded EUR 1.6m Grant for Dengue ResearchExeVir Bio Awarded EUR 1.6m Grant for Dengue Research

ExeVir Bio Awarded EUR 1.6m Grant for Dengue Research

Dengue is a mosquito-borne viral infection listed by WHO as top 10 threat for global health The government grant is…

2 years ago
Bavarian Nordic Reports Phase 3 Topline Results for its COVID-19 Booster Vaccine CandidateBavarian Nordic Reports Phase 3 Topline Results for its COVID-19 Booster Vaccine Candidate

Bavarian Nordic Reports Phase 3 Topline Results for its COVID-19 Booster Vaccine Candidate

Booster study successfully met its primary objective, demonstrating non-inferiority to mRNA-vaccine Regulatory pathway will depend upon the outcome of secondary…

2 years ago
Ocean Biomedical, Inc. Joins the Russell 2000® IndexOcean Biomedical, Inc. Joins the Russell 2000® Index

Ocean Biomedical, Inc. Joins the Russell 2000® Index

Ocean Biomedical’s Inclusion in the Russell 2000® Index and Russell 3000® Index Builds Momentum for Cutting Edge Therapeutic Programs Targeting…

2 years ago
Emergent BioSolutions Announces CEO TransitionEmergent BioSolutions Announces CEO Transition

Emergent BioSolutions Announces CEO Transition

Robert G. Kramer Sr. to Retire Haywood Miller to Serve as Interim CEO GAITHERSBURG, Md., June 27, 2023 (GLOBE NEWSWIRE)…

2 years ago
AC Immune Receives FDA Fast Track Designation for Anti-Amyloid-beta Active Immunotherapy, ACI-24.060, to Treat Alzheimer’s DiseaseAC Immune Receives FDA Fast Track Designation for Anti-Amyloid-beta Active Immunotherapy, ACI-24.060, to Treat Alzheimer’s Disease

AC Immune Receives FDA Fast Track Designation for Anti-Amyloid-beta Active Immunotherapy, ACI-24.060, to Treat Alzheimer’s Disease

AC Immune Receives FDA Fast Track Designation for Anti-Amyloid-beta Active Immunotherapy, ACI-24.060, to Treat Alzheimer’s Disease Ongoing Phase 1b/2 ABATE…

2 years ago
Bioxytran Peer-Reviewed Journal in “Vaccines” Contains Mechanism Capable of Targeting Future COVID-19 MutationsBioxytran Peer-Reviewed Journal in “Vaccines” Contains Mechanism Capable of Targeting Future COVID-19 Mutations

Bioxytran Peer-Reviewed Journal in “Vaccines” Contains Mechanism Capable of Targeting Future COVID-19 Mutations

Complete elimination of viral load in 100% of patients at day 7 vs 6% in placebo (p=.001)Complete elimination of most…

2 years ago
Sutro Biopharma and Blackstone Announce Royalty Financing CollaborationSutro Biopharma and Blackstone Announce Royalty Financing Collaboration

Sutro Biopharma and Blackstone Announce Royalty Financing Collaboration

- Sutro will receive $140 million upfront and is eligible to receive up to an additional $250 million in future…

2 years ago